Literature DB >> 16799550

Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology.

Donald S Kirkpatrick1, Nathaniel A Hathaway, John Hanna, Suzanne Elsasser, John Rush, Daniel Finley, Randall W King, Steven P Gygi.   

Abstract

Protein ubiquitination regulates many cellular processes, including protein degradation, signal transduction, DNA repair and cell division. In the classical model, a uniform polyubiquitin chain that is linked through Lys 48 is required for recognition and degradation by the 26S proteasome. Here, we used a reconstituted system and quantitative mass spectrometry to demonstrate that cyclin B1 is modified by ubiquitin chains of complex topology, rather than by homogeneous Lys 48-linked chains. The anaphase-promoting complex was found to attach monoubiquitin to multiple lysine residues on cyclin B1, followed by poly-ubiquitin chain extensions linked through multiple lysine residues of ubiquitin (Lys 63, Lys 11 and Lys 48). These heterogeneous ubiquitin chains were sufficient for binding to ubiquitin receptors, as well as for degradation by the 26S proteasome, even when they were synthesized with mutant ubiquitin that lacked Lys 48. Together, our observations expand the context of what can be considered to be a sufficient degradation signal and provide unique insights into the mechanisms of substrate ubiquitination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16799550     DOI: 10.1038/ncb1436

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  207 in total

1.  Analysis of ubiquitinated proteome by quantitative mass spectrometry.

Authors:  Chan Hyun Na; Junmin Peng
Journal:  Methods Mol Biol       Date:  2012

2.  Ubiquitin chain trimming recycles the substrate binding sites of the 26 S proteasome and promotes degradation of lysine 48-linked polyubiquitin conjugates.

Authors:  Nan-Yan Zhang; Andrew D Jacobson; Andrea Macfadden; Chang-Wei Liu
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

3.  Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs.

Authors:  Gozde Kar; Ozlem Keskin; Ruth Nussinov; Attila Gursoy
Journal:  J Proteome Res       Date:  2012-01-10       Impact factor: 4.466

4.  Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease.

Authors:  Eric B Dammer; Chan Hyun Na; Ping Xu; Nicholas T Seyfried; Duc M Duong; Dongmei Cheng; Marla Gearing; Howard Rees; James J Lah; Allan I Levey; John Rush; Junmin Peng
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

Review 5.  Structural insights into anaphase-promoting complex function and mechanism.

Authors:  David Barford
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

Review 6.  Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions.

Authors:  Paola Picotti; Ruedi Aebersold
Journal:  Nat Methods       Date:  2012-05-30       Impact factor: 28.547

Review 7.  Characterizing ubiquitination sites by peptide-based immunoaffinity enrichment.

Authors:  Daisy Bustos; Corey E Bakalarski; Yanling Yang; Junmin Peng; Donald S Kirkpatrick
Journal:  Mol Cell Proteomics       Date:  2012-06-23       Impact factor: 5.911

Review 8.  Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes.

Authors:  Min Jae Lee; Byung-Hoon Lee; John Hanna; Randall W King; Daniel Finley
Journal:  Mol Cell Proteomics       Date:  2010-09-07       Impact factor: 5.911

Review 9.  The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration.

Authors:  Ai Yamamoto; Anne Simonsen
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

10.  Distinct consequences of posttranslational modification by linear versus K63-linked polyubiquitin chains.

Authors:  Shengkai Zhao; Helle D Ulrich
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.